Left Menu
Development News Edition

Guj: Modi reviews vaccine development at Zydus Cadila facility

The prime minister will reach Serum Institute campus around 4.30 pm, an official said. Modi's hour-long visit to SII is aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanism, he said.

PTI | Ahmedabad | Updated: 28-11-2020 13:11 IST | Created: 28-11-2020 13:08 IST
Guj: Modi reviews vaccine development at Zydus Cadila facility
Prime Minister Narendra Modi (File Photo/ANI) Image Credit: ANI

Prime Minister Narendra Modi on Saturday visited pharma major Zydus Cadila's manufacturing facility near Ahmedabad, as he began his three-city visit to review ongoing coronavirus vaccine development work. "Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey," Modi tweeted.

Wearing a PPE kit, Modi reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area, over 20 km from Ahmedabad. After his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the promoters and executives of the company, an official said.

Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it has commenced phase-II clinical trials from August. Modi was extensively briefed about the vaccine development work at the plant by the company officials. He was briefed about the vaccine production procedure. He interacted with scientists and vaccine developers, an official said.

Zydus Cadila chairman Pankaj Patel recently said the company is aiming to complete the vaccine trial by March 2021, and could produce up to 100 million doses a year. Modi spent over an hour at the plant, before leaving for the airport, from where he left for Hyderabad at 11.40 am.

In Hyderabad, Modi is scheduled to visit vaccine maker Bharat Biotech's facility. After landing at Hakimpet Air Force station, Modi will reach Bharat Biotech's facility at Genome Valley at 1.30 pm.

The facility is around 50 km from Hyderabad. Bharat Biotech's Covaxin is undergoing phase-3 trials.

After his hour-long visit to the facility, the PM will proceed to Pune, where he will visit the Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for the vaccine. The prime minister will reach Serum Institute campus around 4.30 pm, an official said.

Modi's hour-long visit to SII is aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanism, he said. The PM will fly back to Delhi in the evening, the official said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

Keira Knightley says no interest in filming sex scenes for men

Actress Keira Knightley is no longer interested in doing sex scenes just to appeal to men, she said, calling her no-nudity decision partly a result of having two children. But if a female director was behind the camera, that might be a diff...

Keira Knightley says no interest in filming sex scenes for men

Actress Keira Knightley is no longer interested in doing sex scenes just to appeal to men, she said, calling her no-nudity decision partly a result of having two children. But if a female director was behind the camera, that might be a diff...

Apple's hardware engineering chief to step down to focus on new project

Apple Incs hardware engineering chief, Dan Riccio, will step down to oversee a new project, the iPhone maker said on Monday, providing few details on the longtime executives latest role. Riccio will report to Chief Executive Officer Tim Coo...

AstraZeneca denies report vaccine less effective in elderly

AstraZeneca denied on Monday its COVID-19 vaccine is not very effective for people over 65, after German media reports said officials fear the vaccine may not be approved in the European Union for use in the elderly.German daily papers Hand...

Give Feedback